[an error occurred while processing this directive]
Professor Michael Geist has just tweeted -- quite correctly -- that: "According to the US, over 4.3 billion people live in countries with intellectual property laws worthy of complaint. Many of the countries are poor. The US primary issue for them is demand for stronger patent protection for pharmaceutical drugs."
"No matter how much financial hocus-pocus they use to reclassify revenues to land in the "sexy" buckets (AI, Quantum), it still smells old and musty - just like this company."